Genus Capital Management Inc. Boston Scientific Corp Transaction History
Genus Capital Management Inc.
- $763 Billion
- Q3 2024
A detailed history of Genus Capital Management Inc. transactions in Boston Scientific Corp stock. As of the latest transaction made, Genus Capital Management Inc. holds 118,030 shares of BSX stock, worth $10.7 Million. This represents 1.3% of its overall portfolio holdings.
Number of Shares
118,030Holding current value
$10.7 Million% of portfolio
1.3%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding BSX
# of Institutions
1,542Shares Held
1.19BCall Options Held
6.79MPut Options Held
10.1M-
Vanguard Group Inc Valley Forge, PA131MShares$12 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY126MShares$11.5 Billion0.22% of portfolio
-
State Street Corp Boston, MA62.8MShares$5.72 Billion0.22% of portfolio
-
Primecap Management CO Pasadena, CA37.8MShares$3.44 Billion2.37% of portfolio
-
Wellington Management Group LLP Boston, MA32.8MShares$2.99 Billion0.49% of portfolio
About BOSTON SCIENTIFIC CORP
- Ticker BSX
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,431,609,984
- Market Cap $130B
- Description
- Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...